ISSN: 0010-7824

Journal Home

Journal Guideline

Contraception Q1 Unclaimed

Elsevier Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Contraception is a journal indexed in SJR in Obstetrics and Gynecology and Reproductive Medicine with an H index of 114. It has an SJR impact factor of 1,21 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,21.

Contraception focuses its scope in these topics and keywords: contraceptive, contraception, study, randomized, mifepristone, compared, insertion, initiation, injectable, estradiol, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Obstetrics and Gynecology (Q1) Reproductive Medicine (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,21

SJR Impact factor

114

H Index

168

Total Docs (Last Year)

538

Total Docs (3 years)

3822

Total Refs

1338

Total Cites (3 years)

480

Citable Docs (3 years)

2.64

Cites/Doc (2 years)

22.75

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Human Reproduction Update Q1
American Journal of Obstetrics and Gynecology Q1
Ultrasound in Obstetrics and Gynecology Q1
Obstetrics and Gynecology Q1
Fertility and Sterility Q1

Compare this journals

Aims and Scope

Best articles by citations

Return of fertility following discontinuation of norplantR-II subdermal implants

Analysis of contraceptive failure data in intrauterine device studies

A multicentered clinical trial of the long-acting injectable contraceptive Depo Provera in Chinese women

Prolonged effectiveness of Norplant¬Æ capsule implants: a 7-year study

Nitrites and L-citrulline levels in copper intrauterine device users

Centchroman: A new non-steroidal oral contraceptive in human milk

Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris

Knowledge and willingness to use emergency contraception among low-income post-partum women

A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No.1 given by intramuscular injection to Chinese women

Acceptability of medical abortion with methotrexate and misoprostol

Copper corrosion-simulated uterine solutions

Utilization patterns of oral contraceptives in UK general practice

SHOW MORE ARTICLES

The incidence of actinomyces-like organisms in Papanicolaou-stained smears of copper- and levonorgestrel-releasing intrauterine devices

The Collection and Interpretation of Epidemiological Data About the Cardiovascular Risks Associated With the Use of Steroid Contraceptives

Effectiveness of Norplant¬Æ implants among Thai women in Bangkok

Twelve years of clinical experience with an oral contraceptive containing 30¬µg ethinyloestradiol and 150¬µg desogestrel

The effect of phloroglucinol on pain in first-trimester surgical abortion: a double-blind randomized controlled study

The effect on blood pressure of a monophasic oral contraceptive containing ethinylestradiol and gestodene

Vaginal bleeding patterns in users of Perlutal¬Æ, a once-a-month injectable contraceptive consisting of 10 mg estradiol enanthate combined with 150 mg dihydroxyprogesterone acetophenide

Serum norethindrone levels and menstrual pattern after the use of norethindrone implants in rhesus monkeys

The effects of reformulated 2-rod Norplant¬Æ implant on hemostasis after three years

Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment

Study of the vaginal tolerance to acidform, an acid-buffering, bioadhesive gel

Formation of copper oxychloride and reactive oxygen species as causes of uterine injury during copper oxidation of Cu-IUD